BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28293439)

  • 1. Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia.
    Xia M; Zhao Q; Zhang H; Chen Y; Yuan Z; Xu Y; Zhang M
    Neural Plast; 2017; 2017():6237351. PubMed ID: 28293439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome.
    Zhang MJ; Zhao QC; Xia MX; Chen J; Chen YT; Cao X; Liu Y; Yuan ZQ; Wang XY; Xu Y
    FASEB J; 2020 Jan; 34(1):648-662. PubMed ID: 31914678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection.
    Lei L; Bai G; Wang X; Liu S; Xia J; Wu S; Huan Y; Shen Z
    Toxicol Appl Pharmacol; 2020 Nov; 406():115189. PubMed ID: 32800772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation.
    Bian HT; Xiao L; Liang L; Xie YP; Wang HL; Wang GH
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108259. PubMed ID: 34666303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    Schmitt HM; Schlamp CL; Nickells RW
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice.
    Zhao Q; Zhang F; Yu Z; Guo S; Liu N; Jiang Y; Lo EH; Xu Y; Wang X
    J Neuroinflammation; 2019 May; 16(1):103. PubMed ID: 31101061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R/STAT3/NF-κB65/NLRP3 Activation.
    Sun W; Zhang N; Liu B; Yang J; Loers G; Siebert HC; Wen M; Zheng X; Wang Z; Han J; Zhang R
    ACS Chem Neurosci; 2022 Sep; 13(17):2579-2598. PubMed ID: 35947794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
    Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
    Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGFP966, a selective HDAC3 inhibitor, ameliorates allergic and inflammatory responses in an OVA-induced allergic rhinitis mouse model.
    Zhang W; Sun X; Ba G; Tang R; Lin H
    Int Immunopharmacol; 2021 Apr; 93():107400. PubMed ID: 33529911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection.
    Campo M; Heater S; Peterson GJ; Simmons JD; Skerrett SJ; Mayanja-Kizza H; Stein CM; Boom WH; Hawn TR
    Tuberculosis (Edinb); 2021 Mar; 127():102062. PubMed ID: 33639591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
    Xu Z; Tong Q; Zhang Z; Wang S; Zheng Y; Liu Q; Qian LB; Chen SY; Sun J; Cai L
    Clin Sci (Lond); 2017 Aug; 131(15):1841-1857. PubMed ID: 28533215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models.
    Davis N; Taylor B; Abelleira-Hervas L; Karimian-Marnani N; Aleksynas R; Syed N; Di Giovanni S; Palmisano I; Sastre M
    FASEB J; 2024 May; 38(10):e23659. PubMed ID: 38733301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
    Jia H; Wang Y; Morris CD; Jacques V; Gottesfeld JM; Rusche JR; Thomas EA
    PLoS One; 2016; 11(3):e0152498. PubMed ID: 27031333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner.
    Malvaez M; McQuown SC; Rogge GA; Astarabadi M; Jacques V; Carreiro S; Rusche JR; Wood MA
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2647-52. PubMed ID: 23297220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression.
    Louis Sam Titus ASC; Sharma D; Kim MS; D'Mello SR
    BMC Neurosci; 2019 Dec; 20(1):65. PubMed ID: 31883511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice.
    Suelves N; Kirkham-McCarthy L; Lahue RS; Ginés S
    Sci Rep; 2017 Jul; 7(1):6082. PubMed ID: 28729730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.
    Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ
    Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGFP966 inactivation of the YAP pathway attenuates cardiac dysfunction induced by prolonged hypothermic preservation.
    Zheng XH; Wang LL; Zheng MZ; Zhong JJ; Chen YY; Shen YL
    J Zhejiang Univ Sci B; 2020 Sept.; 21(9):703-715. PubMed ID: 32893527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation.
    Bieszczad KM; Bechay K; Rusche JR; Jacques V; Kudugunti S; Miao W; Weinberger NM; McGaugh JL; Wood MA
    J Neurosci; 2015 Sep; 35(38):13124-32. PubMed ID: 26400942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.
    Qin L; Li G; Qian X; Liu Y; Wu X; Liu B; Hong JS; Block ML
    Glia; 2005 Oct; 52(1):78-84. PubMed ID: 15920727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.